Dickinson MFO, Rodríguez OM

Language: Spanish
References: 20
Page: 66-75
PDF size: 182.75 Kb.

ABSTRACT

Introduction: group B ß-hemolytic streptococcus is a common cause of sepsis and neonatal death,
Objective: to characterize the behavior of the Group B ß-hemolytic streptococcus meningitis in Cuba.
Methods: an observational, descriptive and analytical study was performed on 57 patients suffering meningitis caused by Group B ß-hemolytic streptococcus, with the onset of symptoms ranging from January 1st 1998 to December 2010. The risk was estimated according to the year of occurrence, the age, the province and the municipality as well as the fatality rate and the association of delay in medical diagnosis and in admission to the hospital and death.
Results: the incidence rate of the whole period was 0.03 per 1 000 livebirths and the fatality rate amounted to 31.58 %. The propo9rtion of cases between males and females was very similar (50.9 % and 49.1 % respectively). The infants aged younger than 3 months were more affected by the disease (38 cases) and they accounted for 100 % of those children who died (18 cases). The most risky provinces were Pinar del Rio (9.09 per 1 000 livebirths) and Santiago de Cuba (0.08 per 1 000 livebirths). The municipality with the highest risk index was San Luis in Santiago de Cuba (0.31 per 1 000 livebirhts). The average length of time for medical diagnosis was 17 hours and for admission to the hospital was 5 hours. No association was found between delay in medical diagnosis (RR= 0.66) and in admission to the hospital (RR= 1.22) and death occurrence.
Conclusions: Group B ß-hemolytic streptococcus is a significant preventable cause of meningitis and neonatal death.

REFERENCES

1. Poyart C, Réglier-Poupet H, Tazi A, Billoët A, Dmytruk N, Bidet P, et al. Invasive Group B Streptococcal Infections in Infants, France. Emerg Inf Dis. 2008;14(10):1647-49.

2. Fluegge K, Siedler A, Heinrich B, Schulte-Moenting J, Moennig MJ, Bartels DB. Incidence and Clinical Presentation of Invasive Neonatal Group B Streptococcal Infections in Germany. Pediatrics. 2006;117(6):1139-45

3. Woods CJ, Levy CS. Streptococcus Group B Infections. Drugs, Diseases & Procedures. Medscape [serie en Internet]. 2009 [citado 6 de agosto de 2012]. Disponible en: http://emedicine.medscape.com/article/229091-overview

4. Díaz M, Claver D, Pérez J. Infecciones por Streptococcus agalactiae en un servicio de neonatología abierto. Rev Cubana Pediatr [serie en Internet]. 2008 [citado 6 de agosto de 2012];80(4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312008000400002&lng=en

5. Díaz M, Fernández MT, Moreno O, Piloto R, Arango MI, Díaz J. Infección bacteriana severa en recién nacidos febriles sin signos de focalización. Rev Cubana Pediatr [serie en Internet]. 1998 [citado 6 de agosto de 2012];67(2). Disponible en: http://www.bvs.sld.cu/revistas/ped/vol67_2_95/ped01295.htm

6. Díaz M, Guerra DM, Vega ME, Martínez A, Pérez J, Fernández MT. Infección por estreptococo del grupo B en niños después del período neonatal. Rev Cubana Pediatr [serie en Internet]. 2006 [citado 6 de agosto de 2012];78(4). Disponible en: http://www.bvs.sld.cu/revistas/ped/vol78_04_06/ped01406.html

7. Quintana I, Sotolongo F, Llop A, Cuevas I, Martínez N, Velázquez JC, et al. Programa nacional de prevención y control de los síndromes neurológicos infecciosos. La Habana: MINSAP; 1999.

8. Pérez AE, Dickinson FO, Rodriguez M. Community acquired bacterial meningitis in Cuba: a follow up of a decade. BMC Infectious Diseases [serie en Internet]. 2010 [citado el 10 de agosto de 2012];10:130. Disponible en: http://www.biomedcentral.com/1471-2334/10/130

9. Levent F, Baker C, Rench MA, Edwards MS. Early Outcomes of Group B Streptococcal Meningitis in the 21st Century. Pediatr Infect Dis J. 2010;29(11):1009-12.

10. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005. JAMA. 2008;299(17):2056-65.

11. Edmon KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379(9815):502-3.

12. Lazo E, Guillén D, Zegarra J. Meningitis neonatal en el Hospital Nacional "Cayetano Heredia". Rev Peru Pediatr [serie en Internet]. 2008 [citado 6 de junio de 2012];61(3). Disponible en: http://sisbib.unmsm.edu.pe/bvrevistas/rpp/v61n3/pdf/a04v61n3.pdf

13. Crespo MP, Velez JD. Importancia clínica del Streptococcus agalactiae como causante de infección. Colomb Med. 1996;27:53-8.

14. Rowley DL, Iyasu S, MacDorman MF, Atrash HK. Neonatal and Postneonatal Mortality. CDC'S Public Health Surveillance for women, infants and children. 2012:251-62.

15. Dzupova O, Rozsypal H, Prochazka B, Benes J. Acute bacterial meningitis in adults: Predictors of outcome. Scand J Infect Dis. 2009;41:5:348-54.

16. Karanika M, Vasilopoulou VA, Katsioulis AT, Papastergiou P, Theodoridou MN, Hadjichristodoulou CS. Diagnostic clinical and laboratory findings in response to predetermining bacterial pathogen: data from the Meningitis Registry. PLoS One [serie en Internet]. 2009 [citado 13 de agosto de 2012];4(7):e6426. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714179/pdf /pone.0006426.pdf

17. Radetsky M. Duration of symptoms and outcome in bacterial meningitis: an analysis of causation and the implications of a delay in diagnosis. Pediatr Infect Dis J. 1992;11(9):694-97.

18. Castro BL, Cuellar R. Indicadores de salud infantil en Cuba. Rev Cubana Pediatr. 2009;81(Sup):20-4.

19. Centers for Disease Control and Prevention. Trends in Perinatal Group B Streptococcal Disease-United States, 2000-2006. MMWR. 2009;58(5):109-12.

20. Kumar A, Paoletti LC, Glaser P, Dua M. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol. 2006;4:932-42.